VMCAF

13.0000.00%
GY

Gene Young Cho

Chief Operating Officer

Dr. Gene Young Cho, Ph.D., is Chief Operating Officer of Valuence Merger Corp. I from August 27, 2021. Dr. Cho is General Partner of Valuence Ventures. He is focused on biotech and U.S.A investments. He has leadership and experience in business operations and life sciences. He is the Executive Director of CG Pharmaceuticals, Inc. In this role, Dr. Cho is focused on developing growth strategies as well as providing strategic planning and management of the operations and expansion of CG Pharmaceuticals. Previously, Dr. Cho worked as a life sciences consultant at L.E.K. Consulting, working with clients in biopharmaceuticals, contract services, medical devices, healthcare services, HCIT, digital health, and AI. Some of his specific experiences include working on large-scale M&A transactions of leading biopharmaceuticals or healthcare service companies, supporting target identification for acquisition, implementing pipeline development strategies, and optimizing governance structures of fast-growing biotech companies. He also has strong experience in the Asian markets through his professional network focused around supporting emerging technologies and startups. Dr. Cho is also the author of over 10 publications in journals and several conference abstracts during his time as a researcher. Dr. Cho received B.S. in Bio Engineering from University of California Berkeley.

公司職務